Cancer in children born after frozen-thawed embryo transfer: A cohort study

PLoS Med. 2022 Sep 1;19(9):e1004078. doi: 10.1371/journal.pmed.1004078. eCollection 2022 Sep.

Abstract

Background: The aim was to investigate whether children born after assisted reproduction technology (ART), particularly after frozen-thawed embryo transfer (FET), are at higher risk of childhood cancer than children born after fresh embryo transfer and spontaneous conception.

Methods and findings: We performed a registry-based cohort study using data from the 4 Nordic countries: Denmark, Finland, Norway, and Sweden. The study included 7,944,248 children, out of whom 171,774 children were born after use of ART (2.2%) and 7,772,474 children were born after spontaneous conception, representing all children born between the years 1994 to 2014 in Denmark, 1990 to 2014 in Finland, 1984 to 2015 in Norway, and 1985 to 2015 in Sweden. Rates for any cancer and specific cancer groups in children born after each conception method were determined by cross-linking national ART registry data with national cancer and health data registries and population registries. We used Cox proportional hazards models to estimate the risk of any cancer, with age as the time scale. After a mean follow-up of 9.9 and 12.5 years, the incidence rate (IR) of cancer before age 18 years was 19.3/100,000 person-years for children born after ART (329 cases) and 16.7/100,000 person-years for children born after spontaneous conception (16,184 cases). Adjusted hazard ratio (aHR) was 1.08, 95% confidence interval (CI) 0.96 to 1.21, p = 0.18. Adjustment was performed for sex, plurality, year of birth, country of birth, maternal age at birth, and parity. Children born after FET had a higher risk of cancer (48 cases; IR 30.1/100,000 person-years) compared to both fresh embryo transfer (IR 18.8/100,000 person-years), aHR 1.59, 95% CI 1.15 to 2.20, p = 0.005, and spontaneous conception, aHR 1.65, 95% CI 1.24 to 2.19, p = 0.001. Adjustment either for macrosomia, birth weight, or major birth defects attenuated the association marginally. Higher risks of epithelial tumors and melanoma after any assisted reproductive method and of leukemia after FET were observed. The main limitation of this study is the small number of children with cancer in the FET group.

Conclusions: Children born after FET had a higher risk of childhood cancer than children born after fresh embryo transfer and spontaneous conception. The results should be interpreted cautiously based on the small number of children with cancer, but the findings raise concerns considering the increasing use of FET, in particular freeze-all strategies without clear medical indications.

Trial registration: Trial registration number: ISRCTN 11780826.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Birth Weight
  • Child
  • Cohort Studies
  • Embryo Transfer* / adverse effects
  • Female
  • Humans
  • Infant, Newborn
  • Neoplasms* / epidemiology
  • Neoplasms* / etiology
  • Pregnancy
  • Reproductive Techniques, Assisted / adverse effects
  • Retrospective Studies

Associated data

  • ISRCTN/ISRCTN11780826

Grants and funding

The CoNARTaS has been supported by the Nordic Trial Alliance: a pilot project jointly funded by the Nordic Council of Ministers and NordForsk [grant number 71450] (AP), the Central Norway Regional Health Authorities [grant number 46045000] (SO), the Norwegian Cancer Society [grant number 182356–2016] SO), the Nordic Federation of Obstetrics and Gynaecology [grant numbers NF13041, NF15058, NF16026 and NF17043] (UBW, AT), the Interreg Öresund-Kattegat-Skagerrak European Regional Development Fund (ReproUnion project) (AP), and by the Research Council of Norway’s Centre of Excellence funding scheme [grant number 262700] (SO), the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-70940) (CB), the Hjalmar Svensson Foundation (UBW), and The Swedish Childhood Cancer Foundation (BL). The funding sources had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.